SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-062177
Filing Date
2019-11-12
Accepted
2019-11-12 09:00:24
Documents
4
Period of Report
2019-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-22348_18k.htm 8-K 29285
2 EX-4.1 a19-22348_1ex4d1.htm EX-4.1 94619
3 EX-10.1 a19-22348_1ex10d1.htm EX-10.1 150207
4 GRAPHIC g223481ksi001.jpg GRAPHIC 3750
  Complete submission text file 0001104659-19-062177.txt   280617
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 191206457
SIC: 2834 Pharmaceutical Preparations